5 results match your criteria: "Royal Adelaide Hospital Campus[Affiliation]"
Nat Commun
January 2024
Université Paris Cité, INSERM U970 PARCC, Paris Institute for Transplantation and Organ Regeneration, F-75015, Paris, France.
In kidney transplantation, day-zero biopsies are used to assess organ quality and discriminate between donor-inherited lesions and those acquired post-transplantation. However, many centers do not perform such biopsies since they are invasive, costly and may delay the transplant procedure. We aim to generate a non-invasive virtual biopsy system using routinely collected donor parameters.
View Article and Find Full Text PDFDiabetes
June 2023
Department of Medicine, University of Adelaide, Royal Adelaide Hospital Campus, Adelaide, South Australia, Australia.
Unlabelled: Intrahepatic islet transplantation for type 1 diabetes is limited by the need for multiple infusions and poor islet viability posttransplantation. The development of alternative transplantation sites is necessary to improve islet survival and facilitate monitoring and retrieval. We tested a clinically proven biodegradable temporizing matrix (BTM), a polyurethane-based scaffold, to generate a well-vascularized intracutaneous "neodermis" within the skin for islet transplantation.
View Article and Find Full Text PDFKidney Int Rep
October 2020
College of Medicine and Public Health, Flinders University, SA, Australia.
Diagn Mol Pathol
March 2011
Royal Adelaide Hospital campus, SA Pathology, BreastScreen, SA.
Background: Multiplex ligation-dependent probe amplification (MLPA) is a polymerase chain reaction-based assay that can assess HER2 gene copy number relative to control genes.
Design: Institutional ethics board approval was obtained. Using commercially available kits, 208 consecutive invasive breast cancers undergoing routine in situ hybridization testing (chromogenic in situ hybridization and fluorescence in situ hybridization) were also tested independently by MLPA.
Intern Med J
May 2005
Transfusion Medicine Unit, Royal Adelaide Hospital Campus, Institute of Medical and Veterinary Science, Adelaide, South Australia, Australia.
Aim: To carry out an audit of the appropriateness of fresh-frozen plasma (FFP) and platelets (Plt) transfusion with reference to the Australian National Health and Medical Research Council/Australian Society of Blood Transfusion Clinical Practice Guidelines, and to assess the impact of a self-educating transfusion request form.
Methods: A prospective review of the clinical indications and laboratory data in all transfusion episodes of FFP and Plt occurring in a tertiary teaching hospital in South Australia in two 2-month periods of the years 2002 and 2003.
Results: Reversal of warfarin has emerged as the major indication to transfuse FFP (34%).